Previously Reported In Vitro Data Demonstrating that Individual Omicron Mutations Were Not Associated with ADG20 Escape Do Not Translate to Omicron Authentic and Pseudovirus Assays WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of

LeddarTech invites LiDAR manufacturers, Tier 1-2 suppliers, system integrators and automotive OEMs to discover the latest in ADAS and AD sensing and perception technologies at booth 7061 January 5-8 at CES QUEBEC, Dec. 14, 2021 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate